Ayhan Aşkın, Ayten Özkan, Seciye Eda Bıyıklı, A. Tosun
{"title":"Could There Be a Possible Link Between Vitiligo and Fibromyalgia Syndrome?","authors":"Ayhan Aşkın, Ayten Özkan, Seciye Eda Bıyıklı, A. Tosun","doi":"10.4274/TDD.3611","DOIUrl":null,"url":null,"abstract":"Objective: In this study, it was aimed to determine the frequency of Fibromyalgia syndrome (FMS) in vitiligo patients and to evaluate its relation with clinical parameters. Methods: Thirty-five generalized vitiligo patients and 45 sexand age-matched healthy controls were included in the study. Participant’s demographic and clinical characteristics were determined. All participants were questioned in detail from the point of symptoms and signs of FMS. Clinical and functional evaluations were performed with Fibromyalgia Impact Questionnaire (FIQ), Vitiligo Area Scoring Index (VASI), Pittsburgh Sleep Quality Index (PSQI), visual analogue scale and hospital anxiety and depression scales (HADS). Results: Vitiligo patients’ fatigue, depression, anxiety and sleep quality scores were significantly higher (p<0.05). The frequency of FMS was significantly high in patients with vitiligo than in controls (34.3% vs 11.1%, p=0.015). The vitiligo patients with FMS had higher pain, fatigue, stiffness, FIQ, VASI, HADS and PSQI scores (p<0.05). Significant correlations were obtained between vitiligo severity and clinical parameters. FIQ, VASI, HADS and PSQI scores were detected as an important indicator which a sign of the presence of FMS in vitiligo patients. Conclusion: This study revealed that the frequency of FMS was significantly higher in patients with vitiligo. While the presence of FMS deteriorates the psychological state and sleep quality in vitiligo patients, it also exacerbates the severity of the disease. Therefore, clinicians should be aware of the FMS, which can worsen the clinical and functional status on vitiligo patients.","PeriodicalId":272857,"journal":{"name":"Turkish Journal of Dermatology / Türk Dermatoloji Dergisi","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Dermatology / Türk Dermatoloji Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/TDD.3611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Objective: In this study, it was aimed to determine the frequency of Fibromyalgia syndrome (FMS) in vitiligo patients and to evaluate its relation with clinical parameters. Methods: Thirty-five generalized vitiligo patients and 45 sexand age-matched healthy controls were included in the study. Participant’s demographic and clinical characteristics were determined. All participants were questioned in detail from the point of symptoms and signs of FMS. Clinical and functional evaluations were performed with Fibromyalgia Impact Questionnaire (FIQ), Vitiligo Area Scoring Index (VASI), Pittsburgh Sleep Quality Index (PSQI), visual analogue scale and hospital anxiety and depression scales (HADS). Results: Vitiligo patients’ fatigue, depression, anxiety and sleep quality scores were significantly higher (p<0.05). The frequency of FMS was significantly high in patients with vitiligo than in controls (34.3% vs 11.1%, p=0.015). The vitiligo patients with FMS had higher pain, fatigue, stiffness, FIQ, VASI, HADS and PSQI scores (p<0.05). Significant correlations were obtained between vitiligo severity and clinical parameters. FIQ, VASI, HADS and PSQI scores were detected as an important indicator which a sign of the presence of FMS in vitiligo patients. Conclusion: This study revealed that the frequency of FMS was significantly higher in patients with vitiligo. While the presence of FMS deteriorates the psychological state and sleep quality in vitiligo patients, it also exacerbates the severity of the disease. Therefore, clinicians should be aware of the FMS, which can worsen the clinical and functional status on vitiligo patients.
目的:本研究旨在了解白癜风患者纤维肌痛综合征(FMS)的发病频率,并评价其与临床参数的关系。方法:选取35例全身性白癜风患者和45例性别、年龄相匹配的健康对照。确定参与者的人口学和临床特征。从FMS症状和体征的角度对所有参与者进行了详细的询问。采用纤维肌痛影响问卷(FIQ)、白癜风区域评分指数(VASI)、匹兹堡睡眠质量指数(PSQI)、视觉模拟量表和医院焦虑抑郁量表(HADS)进行临床和功能评价。结果:白癜风患者疲劳、抑郁、焦虑、睡眠质量评分显著高于对照组(p<0.05)。白癜风患者FMS发生频率显著高于对照组(34.3% vs 11.1%, p=0.015)。白癜风合并FMS患者疼痛、疲劳、僵硬、FIQ、VASI、HADS、PSQI评分均高于对照组(p<0.05)。白癜风严重程度与临床参数有显著相关性。FIQ、VASI、HADS和PSQI评分作为白癜风患者FMS存在的重要指标。结论:本研究显示白癜风患者发生FMS的频率明显增高。FMS的存在使白癜风患者的心理状态和睡眠质量恶化的同时,也加重了病情的严重程度。因此,临床医生应该注意FMS,它会使白癜风患者的临床和功能状况恶化。